OMICS PUBLISHING GROUP
About this Journal Contact this Journal Current issue Archive Search Quick Search
OMICS Publishing Group  »  Life Sciences    »    Volume 1.2  

Non-Thermal Effects of Far-Infrared Ray (FIR) on Human Hepatocellular Carcinoma Cells HepG2 and their Tumors

Tatsuo Ishikawa1, Jun Ishibashi2, Kikuji Yamashita1*, Shine-Od Dalkhsuren1, Kaori Sumida1, Takahumi Masui1 and Seiichiro Kitamura1

1Department of Oral and Maxillofacial Anatomy, Medical Science for Oral and Maxillofacial Regeneration, Graduate School of Health Biosciences, University of Tokushima, 3-18-15 Kuramoto, Tokushima, 770-8504 Japan
2Blanka Dental Office
*Corresponding author: Dr . Kikuji Yamashita, Department of Oral and Maxillofacial Anatomy,
Medical Science for Oral and Maxillofacial Regeneration,
Graduate School of Health Biosciences,
University of Tokushima, 3-18-15 Kuramoto,
Tokushima, 770-8504 Japan,
Tel      :
+81-88-6339120,
Fax     :
+81-88-6337320,
E-mail : kikuji@dent.tokushima-u.ac.jp
Received November 03, 2009; Accepted December 29, 2009; Published December 29, 2009
Citation: Ishikawa T, Ishibashi J, Yamashita K, Dalkhsuren SO, Sumida K, et al. (2009) Non-thermal Effects of Far-Infrared Ray (FIR) on Human Hepatocellular Carcinoma Cells HepG2 and their Tumors. J Cancer Sci Ther 1: 078-082. doi:10.4172/1948-5956.1000012
Copyright:© 2009 Ishikawa T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract

Background: We developed a cell culture CO2 incubator and a mice rack that can continuously irradiate cells or murine with FIR. Our goal is to make clear the non-thermal effect of FIR on HepG2 with these instruments morphologically.

Methods: By using them, in vitro , we examined the proliferation of cultured HepG2 cells with hematocytometer, BrdU assay, WST-1 assay, HE staining, Toluidine blue staining and microarray studies. And in vivo, we measured the tumors, observed the sections by IHC, DAPI staining with light microscopes and performed microarray studies.

Results: Proliferation of HepG2 cells were suppressed (e.g., cell count declined by 34% after 10 days of FIR irradiation), tumor volumes reduced by 86% after 30 days of FIR irradiation, mRNA of Vascular Endothelial Growth Factor (VEGF) decreased by 48%, vascular area in cross sections from the tumors decreased 60% compared with the control. More frequent properties in apoptosis were observed by TUNEL and DAPI staining in FIR-treated groups. Body weight of mice increased compared with the control. Oxydation and Reduction (Redox) reactions by H+ (proton and electron)/O2- (a kind of Reactive Oxygen Species (ROS)) were induced by FIR.

Conclusions: These results clarified that FIR inhibited the proliferation of HepG2 at non-thermal circumstances (at 25±0.5, 37±0.5°C). FIR will serve as a tool against diseases induced by HepG2.
 
This Article
» Full Text (PDF)
»
 Full Text (HTML)
Services
» Similar articles in google scholar
» Similar articles in Pub Med
Google Scholar
» Articles by Tatsuo Ishikawa
» Articles by Jun Ishibashi
» Articles by Kikuji Yamashita
Pub Med
» Articles by Tatsuo Ishikawa
» Articles by Jun Ishibashi
» Articles by Kikuji Yamashita